Proposal to award sole supply and change some antiretroviral brands
PHARMAC is seeking feedback on a proposal to make several changes to funding of antiretroviral therapies (ARTs) used in the treatment of HIV infection.
Consultation closes at 4pm on Wednesday, 7 November 2018.
Decision to fund MiniMed 640G and Tandem t:slim X2 insulin pumps and consumables
We’re pleased to announce a decision to list the MiniMed 640G insulin pump and the Tandem t:slim X2 insulin pump and associated consumables from 1 November 2018 for people who meet the Special Authority criteria for access to funded insulin pumps and consumables.
Agreement for the supply of custom designed orthopaedic implants and associated design services supplied by Ossis Limited
We are pleased to announce the approval of a listing agreement with Ossis Limited for the supply of a range of custom designed orthopaedic implants and associated implant design services to DHBs.
RFP - supply of multi-category patient assessment, monitoring and treatment equipment and consumables
PHARMAC invites proposals for the supply of multi-category patient assessment, monitoring and treatment equipment and consumables to New Zealand DHB Hospitals.
All proposals must be submitted to PHARMAC via the Government Electronic Tenders Service (GETS) (www.gets.govt.nz) no later than 4pm NZT Friday 14 December 2018 - RFx ID 20284045.
If you have any questions about this RFP, please post these on the Government Electronic Tenders Service (www.gets.govt.nz).
Answers to questions will be provided through the Government Electronic Tenders Service (GETS). PHARMAC will also post any addenda through GETS. We encourage interested organisations to register with GETS and subscribe to this RFP to be kept up to date.
Decision to list interventional radiology products supplied by Teleflex Medical New Zealand Limited
We are pleased to announce the approval of a listing agreement for a range of interventional radiology products with Teleflex Medical New Zealand Limited.
Evidence-based approach to funding choices more important than ever
Cancer will affect almost all New Zealanders at some point in their lives. Given the range of new treatments in the pipeline, PHARMAC works hard to fund the best medicines it can based on the evidence, says Sarah Fitt, Chief Executive.
RFP - supply of rehabilitation equipment, patient positioning products and supports
PHARMAC invites proposals for the supply of rehabilitation equipment, patient positioning products and supports to New Zealand District Health Board (DHB) hospitals.
All proposals must be submitted to PHARMAC via the Government Electronic Tenders Service (GETS) (www.gets.govt.nz) no later than 4pm NZT Wednesday 5 December 2018 - RFx ID 20264267.
If you have any questions about this RFP, please post these on the Government Electronic Tenders Service (www.gets.govt.nz).
Answers to questions will be provided through the Government Electronic Tenders Service (GETS). PHARMAC will also post any addenda through GETS. We encourage interested organisations to register with GETS and subscribe to this RFP to be kept up to date.
Proposal to decrease price and award sole supply for alendronate
PHARMAC is seeking feedback on a proposal to award sole supply to the currently listed brand of alendronate sodium 70 mg tablets (Fosamax and Fosamax Plus), a treatment for osteoporosis.
Consultation closes at 5pm on Wednesday, 25 October 2018.
RFP - PHARMAC and HRC research partnership 2019
PHARMAC and the Health Research Council of New Zealand request research proposals. Registrations close: 24 October 2018. Full applications close: 7 November 2018.
Electronic portal for bidding on PHARMAC’s annual tender
The electronic portal (e-portal) to host PHARMAC’s annual tender is now available for suppliers to trial.
Before the e-portal goes ‘live’, PHARMAC is providing suppliers with the opportunity to trial and practice with the e-portal and register their company in the system if they have not already done so before the release of the 2018/19 Tender. The practice tender will remain open until midnight on Sunday 21 October 2018.
Proposal to list medical devices supplied by REM SYSTEMS Limited
PHARMAC is seeking feedback on a proposal to list a range of medical devices in Part III of Section H of the Pharmaceutical Schedule from 1 December 2018, through a provisional agreement with REM SYSTEMS Limited.
Closes: 4pm Thursday, 25 October 2018.
Decision to list medical devices supplied by Intermed Medical Limited
We are pleased to announce the approval of a listing agreement with Intermed Medical Limited for the supply of needles and syringes, and respiratory equipment and consumables.
Decision to fund sapropterin
We’re pleased to announce a decision to list sapropterin (Kuvan), a treatment for the rare condition phenylketonuria (PKU), for women who are pregnant or actively planning a pregnancy and require pharmacological support to manage PKU in pregnancy.
September 2018 tender notification
PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2016/17 Invitation to Tender, dated 3 November 2016 and the 2017/18 Invitation to Tender, dated 2 November 2017.
Decision to list urology, ostomy and continence products supplied by Universal Specialities Ltd and Convatec (New Zealand) Ltd
We are pleased to announce the approve of non-exclusive listing agreements with Universal Specialities Limited and Convatec (New Zealand) Limited for the supply of urology, ostomy and continence products to DHBs.
Proposal to list urology, ostomy and continence products supplied by Liberty Medical NZ Limited
PHARMAC is seeking feedback on a proposal to list a range of urology, ostomy and continence products in Part III of Section H of the Pharmaceutical Schedule from 1 January 2019, through a listing agreement with Liberty Medical NZ Limited.
Closes: 4pm Wednesday, 17 October 2018.
Proposal to list interventional radiology products supplied by Bard Australia
PHARMAC is seeking feedback on a proposal to list a range of interventional radiology products in Part III of Section H of the Pharmaceutical Schedule from 1 December 2018 through a provisional agreement with Bard Australia Pty Limited.
Closes: 5pm Wednesday, 17 October 2018.
Agreement for the supply of orthopaedic implants and associated products supplied by Mathys Limited
We are pleased to announce the approval of a listing agreement with Mathys Limited for the supply of orthopaedic implants and associated products to DHBs.
Decision to list medical devices supplied by Jackson Allison Medical & Surgical Limited
We are pleased to announce the approval of a listing agreement with Jackson Allison Medical & Surgical Limited for the supply of interventional radiology products; needles and syringes; and respiratory equipment and consumables.
Decision to change the funded brand of epoetin alfa
PHARMAC is pleased to announce the approval of an agreement with Novartis New Zealand Ltd for the supply of epoetin alfa.
Newsletters
Device Advice: Your update on PHARMAC’s Hospital Medical Devices programme.
Hospital News: News about getting the best value for what we spend on hospital pharmaceuticals.
Inpharmation: News about PHARMAC's activities and pharmaceutical-related issues.
Inpharmation in Hospitals: Hospital news about PHARMAC's activities and pharmaceutical-related issues.
Te Whaioranga ePānui: A PHARMAC newsletter for people with an interest in Māori health.
